| Patients n (%) |
---|---|
Sex | Â |
 male  female | 46 (69.7%) 20 (30.3%) |
Age at diagnosis (years) | Â |
 median  range | 7.9 1.1–18.3 |
Immunophenotype | Â |
 no further specified  early-T  pre-T  cortical  mature | 3 (4.5%) 2 (3%) 14 (21.2%) 28 (42.4%) 19 (28.8%) |
Risk group | Â |
 no data  HR  non-HR | 3 (4.5%) 21 (31.8%) 42 (63.6%) |
WBC (109/L) | Â |
 median  range | 73.5 3.9–765.1 |
Outcome | Â |
 CR1  CR2  exitus | 45 (68.2%) 3 (4.5%) 18 (27.3%) |
Follow up (months) | Â |
 median  range | 86.4 0.3–298.6 |